These findings suggest that antibody binding to the N-terminal domain of stimulator and silent flagellins may impact TLR5 activation in both CD and ME/CFS patients. This evidence concerns the gene TLR5 and myalgic encephalomeyelitis/chronic fatigue syndrome.